MRHB Awarded ‘Best New Islamic Crypto Platform’, Incubated by International Incubation Center of ICYF in Istanbul, Türkiye
31. Januar 2023 03:16 ET
|
MRHB.Network
MELBOURNE, Australia, Jan. 31, 2023 (GLOBE NEWSWIRE) -- MRHB, the world’s first halal decentralized finance (DeFi) ecosystem, has recently bagged two awards from Singapore-based World Business...
Meet the Real Superheroes at Orthopaedic Institute for Children “STAND for KIDS” Gala
06. Juni 2022 12:30 ET
|
Stand for Kids
~Patients And Doctors Celebrated in Emotion-Packed Performance~JULIE BOWEN, GARY COLE, JON HUERTAS plus more…CHRISTOPHER GORHAM, “THE LINCOLN LAWYER,” emceeJonnie Davis, President of ABC Signature...
RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca
08. Oktober 2020 10:30 ET
|
RedHill Biopharma Ltd.
RedHill obtains Israel rights to Movantik® from AstraZeneca, giving RedHill global rights, excluding Europe and Canada--Movantik approved for opioid-induced constipation in Israel under the brand name...
RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®
03. August 2020 07:00 ET
|
RedHill Biopharma Ltd.
RedHill acquired Movantik® for opioid induced constipation from AstraZeneca in April 2020; Movantik® generated $96 million in 2019 --RedHill and Daiichi Sankyo replaced their co-commercialization...
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28. August 2019 07:45 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
09. Juli 2019 08:00 ET
|
BioDelivery Sciences International, Inc.
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE...
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
10. April 2019 16:06 ET
|
BioDelivery Sciences International, Inc.
Long-term revenue potential of over $75 million for NME with IP protection through 2031 Leverages existing commercial capabilities to provide a novel treatment option for OIC ...
Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
12. Juni 2014 14:41 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the...
Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal
06. Mai 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
01. Mai 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...